HBK Investments’s Hims & Hers Health HIMS Stock Holding History

HBK Investments’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-21,000	Closed	-$1.19M	–	285
2025 Q3	$1.19M	Buy	+21,000	New	+$1.08M	0.01%	196

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Defiance ETFs New York $6.98B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HBK Investments's HIMS Position: Q1 2026 in Review

HBK Investments sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 42,088 shares — an estimated $1.37M sold.

HBK Investments first reported a position in HIMS in Q4 2019 and held it in 6 quarters. The position peaked at $10.1M in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

HBK Investments reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
HBK Investments sold 42,088 Hims & Hers Health shares in Q1 2026, an estimated $1.37M.
HBK Investments first reported a position in Hims & Hers Health in Q4 2019 and held it in 6 quarters.
HBK Investments's Hims & Hers Health position peaked at $10.1M in Q3 2025.
434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on HBK Investments's 13F filing for Q1 2026, filed 15 May 2026.